Search results
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Zacks via Yahoo News· 1 week agoVertex Pharmaceuticals Incorporated VRTX has been witnessing strong revenue growth, regulatory...
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Zacks via Yahoo News· 2 weeks agoAgios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo News· 3 weeks agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo News· 4 weeks agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo News· 2 months agoEditas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wider...
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo News· 2 months agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo News· 2 months agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo News· 2 months agoOn CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on...
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks via Yahoo News· 2 months agoAgios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark,...